Inmune Bio (INMB) EBT (2018 - 2025)
Historic EBT for Inmune Bio (INMB) over the last 7 years, with Q3 2025 value amounting to -$7.4 million.
- Inmune Bio's EBT rose 3950.02% to -$7.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$51.4 million, marking a year-over-year decrease of 2365.75%. This contributed to the annual value of -$42.6 million for FY2024, which is 4207.88% down from last year.
- Inmune Bio's EBT amounted to -$7.4 million in Q3 2025, which was up 3950.02% from -$24.6 million recorded in Q2 2025.
- In the past 5 years, Inmune Bio's EBT ranged from a high of -$4.5 million in Q1 2021 and a low of -$24.6 million during Q2 2025
- In the last 5 years, Inmune Bio's EBT had a median value of -$8.4 million in 2023 and averaged -$8.9 million.
- Data for Inmune Bio's EBT shows a peak YoY increase of 3950.02% (in 2025) and a maximum YoY decrease of 14907.25% (in 2025) over the last 5 years.
- Over the past 5 years, Inmune Bio's EBT (Quarter) stood at -$9.0 million in 2021, then soared by 37.52% to -$5.6 million in 2022, then tumbled by 48.51% to -$8.4 million in 2023, then fell by 12.98% to -$9.5 million in 2024, then grew by 21.49% to -$7.4 million in 2025.
- Its last three reported values are -$7.4 million in Q3 2025, -$24.6 million for Q2 2025, and -$9.9 million during Q1 2025.